Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04592588
Other study ID # 843879
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 19, 2020
Est. completion date December 30, 2021

Study information

Verified date July 2023
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, we are conducting a randomized controlled trial with Indian college students. Students will be randomized to the COMET condition or to a wait-list control condition. Primary outcome measures (depressive symptoms, anxiety symptoms, and subjective well-being) will be measures at two weeks post-intervention, four weeks post-intervention, and twelve weeks post-intervention. We will evaluate COMET as a universal intervention (using the full sample) and as a targeted intervention (analyzing those who reported elevated depressive symptoms or anxiety symptoms at baseline).


Recruitment information / eligibility

Status Completed
Enrollment 513
Est. completion date December 30, 2021
Est. primary completion date August 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: At least 18 years old and a student at a participating university in India.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Common Elements Toolbox
COMET is an online unguided self-help intervention that lasts approximately 45-60 minutes.
Wait-list control
Participants in the control condition will receive access to the intervention after data collection for the study has been completed.

Locations

Country Name City State
India Ashoka University New Delhi
India Jindal Global University Sonipat

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Ashoka University, Jindal Global University

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Patient Health Questionnaire-9 (PHQ-9) Depression questionnaire. Scores range from 0 to 27. Lower scores indicate less depression. Up to 12 weeks post-intervention
Primary Change in Generalized Anxiety Disorder Screener-7 (GAD-7) Anxiety questionnaire. Total scores range from 0-21. Lower scores indicate less anxiety. Up to 12 weeks post-intervention
Primary Change in the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) Subjective Well-being questionnaire. Total scores range from 7 to 35. Higher values indicate higher well-being scores. Up to 12 weeks post-intervention
Secondary Ratings on the Acceptability of Intervention Measure (AIM) Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate higher acceptability ratings. Immediately after the intervention
Secondary Ratings on the Intervention Appropriateness Measure (IAM) Questionnaire measuring the appropriateness of an intervention. Appropriateness refers to the perceived fit or relevance of an intervention. The total score ranges from 4 to 20. Higher scores indicate higher appropriateness. Immediately after the intervention
Secondary Mechanisms of Change Participants answered questions relating to each module's mechanism of change on a 7-point Likert Scale, from "strongly disagree" to "strongly agree".
Specifically, we asked participants:
How capable they feel about managing negative thoughts If they will intentionally spend time doing activities they enjoy If they will notice and appreciate good things
Up to 12 weeks post-intervention
Secondary Ability to Cope with COVID-19 2 questions related to their ability to cope with stressors over the upcoming weeks (including challenges relating to COVID-19). Participants answered these questions on a 7-point Likert Scale, from "strongly disagree" to "strongly agree". Specifically, we asked participants:
if they will be able to handle lifestyle changes due to the coronavirus, if the pandemic will have an extremely negative impact on their life.
Up to 12 weeks post-intervention
Secondary Secondary Control We asked participants three items to assess secondary control (Weisz et al., 2010). The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true").
The three items are:
When something bad happens, I can find a way to think about it that makes me feel better.
After a really hard day, I can make myself feel better by remembering some good things that happened.
When bad things happen to me that I can't control, there are lots of things I can do to feel better.
Higher scores indicate greater secondary control.
Up to 12 weeks post-intervention
Secondary Perceived Utility Participants were asked to rate three items relating to the perceived utility of each module. Specifically, we asked participants:
How helpful the module was How engaging the module was How much they will continue applying content from the module Higher scores indicate greater perceived utility.
Immediately after the intervention
Secondary Positive and Negative Affect Schedule Questionnaire measuring positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect. Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect Up to 12 weeks post-intervention
Secondary Perceived Stress Scale-4 Questionnaire measuring perceived stress. Scores range from 0-16, with higher scores indicating greater stress. Up to 12 weeks post-intervention
Secondary The Social Connectedness Scale Questionnaire measuring social connectedness. Scores range from 8 to 48, with higher scores indicating greater social connectedness. Up to 12 weeks post-intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting NCT05302167 - Molehill Mountain Feasibility Study. N/A
Completed NCT05881681 - A Mindfulness Approach to UA for Afro-descendants N/A
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Completed NCT05585749 - Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients N/A
Terminated NCT03272555 - WILD 5 Wellness: A 30-Day Intervention N/A
Recruiting NCT05997849 - Development of a Multiplatform Mental Health Mobile Tool N/A
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care